Valuation: Molecure S.A.

Market Cap 113M 28.44M 25.63M 23.68M 21.41M 40.5M 2.67B 41.5M 284M 1.43B 107M 104M 4.55B P/E 2025 *
-
P/E 2026 * -9.15x
Enterprise Value 82.21M 20.67M 18.63M 17.21M 15.56M 29.44M 1.94B 30.16M 206M 1.04B 77.57M 75.92M 3.3B EV / Sales 2025
19.2x
EV / Sales 2026 * 16.1x
Free-Float
70.71%
Yield 2025 *
-
Yield 2026 * -
1 day+2.02%
1 week-0.18%
Current month-3.81%
1 month-15.89%
3 months-10.18%
6 months+2.96%
Current year-15.76%
1 week 5.25
Extreme 5.25
5.64
1 month 5.16
Extreme 5.16
6.79
Current year 4.98
Extreme 4.98
9.04
1 year 4.98
Extreme 4.98
9.04
3 years 4.98
Extreme 4.98
22.5
5 years 4.98
Extreme 4.98
42.3
10 years 4.98
Extreme 4.98
80.4
Manager TitleAgeSince
Chief Executive Officer - 30/11/2012
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 02/01/2023
Director TitleAgeSince
Director/Board Member - 29/06/2021
Chairman 38 31/05/2023
Director/Board Member - 13/01/2022
Date Insider Type Main position Quantity % Market Cap. Importance
22/12/23 Buy

Chief Executive Officer

49,000 0.2910%
Change 5-day change 1-year change 3-year change Capi.($)
+2.02%-0.18%-7.33%-68.87% 28.44M
+1.10%+1.03%+62.53%+70.47% 67.53B
+0.23%+7.48%+12.67%+90.52% 60.74B
-0.03%-1.37%+19.58%+97.62% 55.66B
+0.11%+8.79%+11.60%+111.86% 47.97B
-0.90%+2.65%+23.10%+40.40% 45.24B
-1.36%+0.78%+171.96%+811.09% 39.08B
+1.97%+4.75%+27.30%+52.81% 35.34B
-1.50%-3.22%+78.99%+55.80% 33.45B
-2.50%+10.10%-38.40%+401.00% 26.49B
Average -0.17%+2.02%+36.20%+166.27% 41B
Weighted average by Cap. -0.19%+2.88%+41.30%+167.51%

Financials

2025 2026 *
Net sales 3.9M 981K 884K 816K 738K 1.4M 91.96M 1.43M 9.78M 49.25M 3.68M 3.6M 157M 7.27M 1.83M 1.65M 1.52M 1.38M 2.6M 171M 2.67M 18.23M 91.77M 6.86M 6.71M 292M
Net income -21.2M -5.33M -4.8M -4.44M -4.01M -7.59M -500M -7.78M -53.19M -268M -20M -19.58M -852M -32.97M -8.29M -7.47M -6.9M -6.24M -11.8M -777M -12.1M -82.71M -416M -31.11M -30.44M -1.32B
Net Debt -30.9M -7.77M -7M -6.47M -5.85M -11.06M -729M -11.34M -77.53M -390M -29.16M -28.54M -1.24B 3.9M 981K 884K 816K 738K 1.4M 91.96M 1.43M 9.78M 49.25M 3.68M 3.6M 157M
Projected Income Statement - Annual - Molecure S.A.
Logo Molecure S.A.
Molecure SA, formerly known as Oncoarendi Therapeutics SA, is a Poland-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing therapeutics for neoplastic and inflammatory diseases. The Company's business model is focused on drug discovery and development, with its core strength in medicinal chemistry and preclinical biology, enhanced by scientific collaborations in specific disease areas. The Company has a platform of 3 distinct small molecule programs targeting chitinases hydrolytic enzymes with potential utility in diverse inflammatory and fibrotic diseases of high unmet medical need. Additionally, it has initiated a program focused on development of small molecule immune modulators to stop the ability of tumors to escape immune surveillance.
Employees
71
Date Price Change Volume
12/11/26 PLN 5.560 +2.02% 18,601
10/11/26 PLN 5.490 +0.73% 37,652
09/11/26 PLN 5.450 -1.98% 33,671
06/11/26 PLN 5.560 -0.18% 23,579
05/11/26 PLN 5.570 +5.09% 69,375
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.490PLN
Average target price
12.80PLN
Spread / Average Target
+133.15%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Molecure S.A.